Sellas logo

Sellas

Stock
Stock
Ticker: SLS
SLS

Price

Price

CHART BY

Historical dividends and forecast

 


$1,741.00

CHART BY

Frequently asked questions

The market capitalization of Sellas is $3.66B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
Sellas's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$0.199. EPS indicates the company's profitability on a per-share basis.
Currently, 2 analysts cover Sellas's stock, with a consensus target price of $37.50. Analyst ratings provide insights into the stock's expected performance.
Sellas's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$39.45M. EBITDA measures the company's overall financial performance.
Sellas has a free cash flow of -$27.30M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
Sellas employs approximately 13 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
The free float of Sellas is 201.59M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$3.66B
EPS (TTM) 
-$0.199
Free Float 
201.59M
EBITDA (TTM) 
-$39.45M
Free Cashflow (TTM) 
-$27.30M

Pricing

1D span
$13.39$17.93
52W span
$1.39$24.89

Analyst Ratings

The price target is $37.50 and the stock is covered by 2 analysts.

Buy

2

Hold

0

Sell

0

Information

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

Employees
13
Industries
Major Pharmaceuticals
Sector
Health Care

Identifier

Primary Ticker
SLS

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation